Indoco Remedies gets final nod from US FDA for Lacosamide tablet
The approval granted by the US Food and Drug Administration (FDA) for Lacosamide tablets is for strengths of 50 mg, 100 mg, 150 mg…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indoco Remedies
Indoco’s CRO AnaCipher receives UKMHRA accreditation
A virtual inspection was carried out from 4th to 7th May and 10th to 11th May, 2021
Indoco launches Brinzolamide Ophthalmic Suspension 1% in US by Teva Pharma
It is used to treat high pressure inside the eye due to ocular hypertension and open-angle glaucoma
Indoco launches favipiravir 400 mg tablets
Fevindo - 400 will be made available at all government approved COVID care centres and selected medical practitioners across the…
Indoco gets USFDA approval for Olanzapine tablets
Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder
Indoco announces Q4FY20 financial results; revenues stand at Rs 263 Crores
The company recorded a net profit of Rs 5.4 crores, as against Rs 11.6 crores, same quarter last year
Indoco receives US FDA approval for Succinylcholine Chloride Injection USP
Succinylcholine Chloride Injection is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to…
India’s tryst with destiny
Sundeep V Bambolkar, Joint Managing Director, Indoco Remedies outlines several measures that the Indian government must implement…
Pharmexcil requests DGFT for guidelines on procedural formalities to export paracetamol, HCQ
India has already shipped 35.82 lakh tablets of hydroxychloroquine to the US, and 11.7 lakh paracetamol tablets to the UK
Indoco receives approval for Febuxostat Tablets from US FDA
The market size of Febuxostat Tablets in USA is over USD 500 million